A heart transplant replaces a failing heart with a healthy one from a deceased donor. The surgery itself takes roughly four to six hours, but the full process spans months or years, from evaluation and waiting for a matched donor to lifelong medication afterward. About 80% of adult recipients survive at least five years, making it one of the most successful organ transplants performed today.
Who Needs a Heart Transplant
Heart transplants are reserved for people whose hearts are failing severely enough that no other treatment can keep them alive. The most common reasons include advanced heart failure from coronary artery disease, cardiomyopathy (where the heart muscle itself is damaged or weakened), and congenital heart defects. Candidates have typically exhausted other options: medications, stents, bypass surgery, and lifestyle changes have all stopped working.
Not everyone with severe heart failure qualifies. Transplant centers screen for conditions that would make the surgery too risky or reduce its chances of success. Active cancer within the past five years, irreversible kidney or liver dysfunction, severe vascular disease, and insulin-dependent diabetes with organ damage can all disqualify a candidate. The evaluation also looks at psychological readiness and whether the person has a reliable support system, since recovery and lifelong follow-up demand consistent commitment.
Finding a Matching Donor
Once approved, a patient joins the national transplant waiting list managed by the Organ Procurement and Transplantation Network. Matching depends on several factors: blood type, body size, how urgently the patient needs the heart, how long they’ve been waiting, and the distance between the donor hospital and the transplant center. Age matters too, with pediatric donors generally matched to pediatric recipients.
Distance is a hard constraint because a donor heart has the shortest preservation window of any transplantable organ. Hearts are typically transplanted within six hours of removal, though newer storage techniques at controlled temperatures have pushed that window beyond ten hours in some cases. Still, geography limits which donors are viable for which recipients, and a heart offer can come at any hour with very little notice.
Median wait times vary by urgency. For all listed patients, the median wait is around 21 days, though some wait significantly longer. Between 2019 and 2022, median wait times increased slightly, from about 18 days to 23 days, reflecting growing demand.
Staying Alive While Waiting
Many patients are too sick to simply wait at home. A left ventricular assist device, or LVAD, is a mechanical pump surgically connected to the heart that helps push blood through the body. It doesn’t replace the heart. Instead it takes over much of the work that the weakened left ventricle can no longer do on its own. This is called a “bridge to transplant.”
LVADs do more than buy time. By supporting circulation, they allow other organs like the kidneys and liver to recover function. They can also lower pressure in the lungs, which is important because high lung pressure can actually disqualify someone from receiving a transplant. When the donor heart arrives, the LVAD is removed during surgery.
What Happens During Surgery
The operation begins with a full sternotomy, where the surgical team opens the breastbone to access the chest cavity. The patient is connected to a heart-lung bypass machine, which takes over the job of circulating and oxygenating blood so the surgeons can safely stop and remove the diseased heart.
Removing the old heart involves carefully disconnecting it from the major blood vessels: the aorta, the pulmonary artery, and the large veins returning blood from the body. Surgeons leave portions of the left atrium (the upper chamber that receives blood from the lungs) in place to serve as attachment points for the new heart. Any pacemaker or defibrillator leads inside the heart are cut and removed.
The donor heart is then positioned in the chest and sewn to the remaining tissue. Surgeons connect the left atrium first, then the large veins, and finally the aorta and pulmonary artery. Carbon dioxide is continuously flushed through the open chest cavity during the procedure to reduce the risk of air bubbles entering the bloodstream. Once all connections are secure, blood flow is restored to the new heart, which usually begins beating on its own or with a small electrical stimulus. The bypass machine is disconnected, and the breastbone is closed.
The First Days of Recovery
Most patients spend two to three days in the ICU immediately after surgery. You’ll be on a breathing machine for at least six to eight hours while the anesthesia wears off. During this early period the medical team closely monitors heart function, watches for bleeding, and begins the critical process of preventing rejection.
The new heart is, from your immune system’s perspective, foreign tissue. Without intervention, your body would attack it. This is why immunosuppressive medication begins almost immediately and continues for life.
Lifelong Immunosuppression
Preventing rejection requires a carefully layered drug regimen. About 40 to 50 percent of transplant programs use what’s called induction therapy: an intense burst of immune suppression right after surgery, when the risk of rejection is highest. This early treatment also protects the kidneys by allowing doctors to delay certain medications that can be hard on kidney function.
After that initial phase, patients transition to maintenance therapy, a daily combination of drugs they’ll take for the rest of their lives. A typical regimen includes a drug that blocks the immune signals telling white blood cells to attack the new heart, a second drug that slows immune cell reproduction, and often a steroid to broadly dampen inflammation. Doses are adjusted over time based on blood tests and biopsy results, with the goal of using the lowest effective amount to minimize side effects.
The tradeoff is real. Suppressing the immune system prevents rejection but also makes you more vulnerable to infections, can raise blood pressure and cholesterol, and increases long-term cancer risk. Regular monitoring, including periodic heart biopsies where a tiny tissue sample is taken through a catheter, helps the transplant team catch rejection early and fine-tune medications.
Long-Term Risks After Transplant
The biggest long-term threat to a transplanted heart is cardiac allograft vasculopathy, or CAV. This is a form of chronic rejection where the recipient’s immune system gradually damages the blood vessels inside the donor heart. Over years, the arteries narrow and stiffen, reducing blood flow to the heart muscle.
What makes CAV especially dangerous is that transplant recipients usually can’t feel it happening. The donor heart doesn’t develop new nerve connections to the recipient’s nervous system, so the chest pain that would normally signal a heart attack is absent. Silent heart attacks are a major concern. By the time arterial damage shows up on imaging, a patient may have already experienced heart attacks without knowing it. This is why transplant centers schedule regular screening tests even when a patient feels perfectly fine.
Survival and Quality of Life
According to the most recent national data from 2023, five-year survival for adult heart transplant recipients is 80.3%. Pediatric recipients fare slightly better at 84.4%. Adults with congenital heart disease have the lowest five-year survival among diagnostic groups, at 76.1%, partly due to the complexity of their anatomy.
For most recipients, a successful transplant means a dramatic improvement in daily life. Activities that were impossible with a failing heart, like walking, climbing stairs, and exercising moderately, become routine again. The commitment to medications, follow-up appointments, and lifestyle adjustments is significant, but for someone who was previously facing end-stage heart failure, the trade is overwhelmingly worthwhile.